Akebia Therapeutics, Inc. (AKBA)

NASDAQ: AKBA · Real-Time Price · USD

Compare

1.440

+0.070 (5.11%)

At close: Jan 22, 2026, 4:00 PM EST

1.450

+0.010 (0.69%)

After-hours: Jan 22, 2026, 7:57 PM EST

Akebia Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Revenue	225.07	160.18	194.62	292.48	211.65	294.64	Upgrade
Revenue Growth (YoY)	32.49%	-17.70%	-33.46%	38.19%	-28.17%	-12.05%	Upgrade
Cost of Revenue	37.55	26.15	39.76	22.5	81.49	63.96	Upgrade
Gross Profit	187.53	134.03	154.86	269.99	130.16	230.68	Upgrade
Selling, General & Admin	109.07	106.55	100.23	138.6	174.14	154.1	Upgrade
Research & Development	47.5	37.65	63.08	129.99	147.85	218.49	Upgrade
Amortization of Goodwill & Intangibles	9.01	36.04	36.04	36.04	36.04	32.62	Upgrade
Operating Expenses	165.57	180.24	199.35	304.63	358.03	405.2	Upgrade
Operating Income	21.95	-46.21	-44.5	-34.64	-227.88	-174.52	Upgrade
Interest Expense	-26.23	-18.19	-6.03	-15.69	-20.02	-8.92	Upgrade
Interest & Investment Income	-	-	-	-	0.07	-	Upgrade
Other Non Operating Income (Expenses)	-6.81	-0.24	0.89	3.15	2.41	1.86	Upgrade
EBT Excluding Unusual Items	-11.08	-64.63	-49.64	-47.18	-245.42	-181.58	Upgrade
Merger & Restructuring Charges	-	-0.06	-0.18	-15.93	-21.58	-68.24	Upgrade
Gain (Loss) on Sale of Investments	-	-	-	-	0.02	0.05	Upgrade
Asset Writedown	-4.21	-4.21	-1.58	-30.24	-15.05	-135.07	Upgrade
Other Unusual Items	-	-0.52	-0.52	-0.87	-	-	Upgrade
Pretax Income	-15.29	-69.41	-51.93	-94.23	-282.02	-384.84	Upgrade
Income Tax Expense	0.62	-	-	-	-	-	Upgrade
Net Income	-15.91	-69.41	-51.93	-94.23	-282.02	-384.84	Upgrade
Net Income to Common	-15.91	-69.41	-51.93	-94.23	-282.02	-384.84	Upgrade
Shares Outstanding (Basic)	245	211	187	183	166	138	Upgrade
Shares Outstanding (Diluted)	245	211	187	183	166	138	Upgrade
Shares Change (YoY)	20.49%	12.53%	2.56%	10.14%	19.85%	16.95%	Upgrade
EPS (Basic)	-0.06	-0.33	-0.28	-0.52	-1.70	-2.78	Upgrade
EPS (Diluted)	-0.06	-0.33	-0.28	-0.52	-1.70	-2.78	Upgrade
Free Cash Flow	32.17	-40.69	-23.38	-73.27	-253.02	-110.71	Upgrade
Free Cash Flow Per Share	0.13	-0.19	-0.13	-0.40	-1.52	-0.80	Upgrade
Gross Margin	83.32%	83.68%	79.57%	92.31%	61.50%	78.29%	Upgrade
Operating Margin	9.75%	-28.85%	-22.86%	-11.84%	-107.67%	-59.23%	Upgrade
Profit Margin	-7.07%	-43.33%	-26.68%	-32.22%	-133.25%	-130.61%	Upgrade
Free Cash Flow Margin	14.29%	-25.40%	-12.02%	-25.05%	-119.55%	-37.57%	Upgrade
EBITDA	32.25	-8.7	-6.87	3.06	-189.91	-139.83	Upgrade
EBITDA Margin	14.33%	-5.43%	-3.53%	1.04%	-89.73%	-47.46%	Upgrade
D&A For EBITDA	10.29	37.5	37.63	37.7	37.97	34.69	Upgrade
EBIT	21.95	-46.21	-44.5	-34.64	-227.88	-174.52	Upgrade
EBIT Margin	9.75%	-28.85%	-22.86%	-11.84%	-107.67%	-59.23%	Upgrade
Revenue as Reported	225.07	160.18	194.62	292.48	211.65	294.64	Upgrade
Advertising Expenses	-	4.6	1	6.7	8.2	5	Upgrade

Updated Nov 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q